DarioHealth Initiates Strategic Review Amid Growing Interest in Digital Health Solutions

DarioHealth Announces Strategic Review

DarioHealth Corp., a prominent player in the realm of digital health solutions focused on chronic condition management, has announced a strategic review process following multiple unsolicited expressions of interest. This initiative, aimed at maximizing shareholder value, signifies a critical juncture for the company. The Board of Directors has formed a special committee comprising independent directors and has engaged Perella Weinberg Partners as its financial advisor to explore a broad spectrum of strategic opportunities, including potential sales, mergers, or ongoing standalone strategies.

Recent Developments

In a significant move to enhance its capital structure, DarioHealth recently completed the conversion of outstanding preferred shares into common stock. This transition fosters a clearer and more transparent equity structure, positioning Dario favorably for future growth opportunities. Additionally, the company successfully concluded an oversubscribed private placement, raising $17.5 million, which bolstered its cash reserves to approximately $40 million by the end of Q2 2025.

Lawrence Leisure, Co-Chair of the Special Committee, emphasized the strength of Dario's multi-condition digital health platform, backing it with clinical evidence and a growing commercial focus. With a simplified cap table and enhanced balance sheet, Dario is in a robust position to continue delivering high-quality solutions to its clients and partners. This proactive measure also allows the company to assess strategic options effectively amidst escalating commercial momentum.

Though the Board of Directors has yet to establish a timeline for the review's completion and has not made any definitive decisions regarding potential transactions, DarioHealth's commitment to transparency indicates the seriousness of its evaluation process. The company has refrained from further commentary until it deems it necessary or appropriate to disclose more information.

About DarioHealth Corp.

DarioHealth Corp. is revolutionizing chronic condition management with its user-centric digital therapeutics platform. This innovative platform delivers personalized interventions powered by data analytics and individualized coaching to help consumers manage diabetes, hypertension, weight, musculoskeletal pain, and behavioral health.

By shifting from traditional episodic healthcare to continuous, tailored care, DarioHealth empowers individuals to make sustainable lifestyle changes, thereby enhancing user satisfaction and retention. The company's solutions are widely distributed to health plans, providers, and self-insured employers globally, reaffirming its leadership in the digital health landscape.

For further details about DarioHealth's offerings and strategic initiatives, visit DarioHealth's Official Website.